Managing Drug Discovery and Protecting Patent Data

摘要

IDBS is pleased to announce that the Australian pharmaceutical company, Cancer Therapeutics CRC, has selected both E-WorkBook and ActivityBase to manage its drug discovery and development on a global multi-site basis. CTx invests in newly discovered drug targets or compounds considered 'high risk' by many biotech and pharmaceutical companies. Consisting of 11 different organisations collaborating in cancer therapeutics research, CTx works closely with leading Australian researchers and institutes to discover, protect and develop small molecule discoveries into preclinical drug candidates with commercial potential.